Biotech Co.* | Agbiotech Partner | Type/Product Area | Terms/Details (Date) |
| | |||
Affymetrix Inc. (AFFX) | Monsanto Co. (NYSE:MON) | Custom supply agreement for Affymetrix's GeneChip technology | Monsanto will use the technology in its research to improve food quality while enhancing crop yield and reducing the need for chemical inputs (3/26) |
AniGenics Inc.* | Veterinary Infectious Disease Organization, the University of Saskatchewan, the University of British Columbia, Simon Fraser University and Inimex Pharmaceuticals Inc.* (Canada) | Collaborative research program sponsored by Genome Canada | The program will begin in the summer and focus on infectious disease genomics of cattle and poultry; it is a three-year, C$27M (US$17.5M) program (5/24) |
Athenix Corp.* | AgraQuest Inc.* | Agreement in which the companies will provide each other access to their respective microbial collections | AgraQuest focuses on environmentally friendly natural pest management products; Athenix is developing genetic solutions for selected industrial uses (3/6) |
Celera Genomics Group (NYSE: CRA) | MetaMorphix Inc.* | Agreement for the sale of Celera's AgGen animal genomics and genotyping business to MetaMorphix | MetaMorphix also received a subscription to the Celera Discovery System and it intends to commercialize products derived from Celera's livestock genomic databases; Celera acquired a minority interest in MetaMorphix and is entitled to share future revenue generated from products based on Celera's livestock databases (3/4) |
Ceres Inc.* | Monsanto Co. (NYSE:MON) | Agreement to improve agricultural harvests | Monsanto acquires rights to Ceres' technologies for certain undisclosed crops and applications; Ceres will receive payments over several years, and could see further payments; Monsanto will fund the program, and has made an investment in Ceres; the deal is worth up to $137M, not including royalties (4/2) |
Codexis Inc. (subsidiary of Maxygen Inc.; MAXY) | Cargill Dow LLC* | Agreement focused on the development of a synthesis for a raw material for Cargill's NatureWorks polylactide | Codexis will apply its protein modification technologies toward creating a natural-based process for the production of lactic acid (4/17) |
ExonHit Therapeutics SA* (France) | Roche Applied Science (unit of Roche Diagnostics of F. Hoffmann-La Roche Ltd.; Switzerland) | Research contract agreement to develop tests for bovine spongiform encephalopathy in living animals | The companies will combine their technologies and work to identify RNA signatures in bovine blood that correlate to BSE infection; they intend to develop a BSE test within 12 months (5/13) |
Hyseq Pharma- | BASF Plant Science LLC (unit of BASF AG; Germany; NYSE:BF; FSE:BAS; LSE:BFA) | Modified agreement in which Hyseq is accelerating the completion of a collaboration that was supposed to continue until mid-2003 and called for Hyseq to receive up to $60M for providing gene sequencing on 12 plant species | To date, Hyseq has worked on eight plant species and received $40M from the collaboration; the new arrangement frees Hyseq from doing any additional species (5/15) |
InterLink Bio- | Fort Dodge Animal Health (division of Wyeth; NYSE: WYE) | Collaborative research agreement in which Interlink will provide access to its libraries of natural products to screen for new antiparasitic compounds for animal use | Fort Dodge will pay access fees, milestone payments and royalties for use in the field of animal health; Interlink has rights for use in the field of crop protection, for which Fort Dodge would receive royalties (5/6) |
Lynx Thera- | Aventis CropScience GmbH (unit of Aventis SA; France; NYSE:AVE) | Agreement to jointly develop and commercialize an assay based on Lynx's bead-based technologies | The companies will jointly own the assay; Lynx will manufacture and sell the services or products based on the assay technology, and will pay royalties to Aventis; Lynx also will perform genomics discovery services for Aventis (4/1) |
MaxyAg Inc. (unit of Maxygen Inc.; MAXY) | Delta and Pine Land Co. (NYSE:DLP) | Agreement to form DeltaMax Cotton LLC to create, develop and commercialize genetically enhanced traits for the cotton seed market | Each company will own 50% of the venture; DeltaMax will contract research and development activities to MaxyAg, D&PL and third parties when appropriate (5/28) |
Naturol Inc. (subsidiary of Coronado Explorations Ltd.; OTC BB: COOX) | Prince Edward Island Food Technology Centre (Canada) | Research project partnership to extract taxanes from Canadian yew trees | The recent commissioning of a Naturol extract processing plant on a pilot scale at the center has made the project possible (3/6) |
| | |||
Notes: | |||
This chart contains information on new and revised corporate agreements in agricultural biotechnology covering the time between 12/27/01 and 5/30/02. | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise indicated, shares are traded on the Nasdaq exchange. | |||
FSE = Frankfurt Stock Exchange; LSE = London Stock Exchange; NYSE = New York Stock Exchange; OTC BB = Over the Counter Bulletin Board | |||
